Through continual advancements in science and technology, biotech stays at the forefront of innovation. From revolutionary approaches to breakthrough discoveries, the ability to cross sectors and disrupt industry norms has biotech creating a new landscape to which leaders need to constantly adjust. Join fellow alumni and industry experts as we examine the crucial intersections of emerging biotech, startups, funding, and regulatory frameworks.
Flow of Event:
- 8:00–8:45 a.m. — Registration, Breakfast and Coffee, Networking
- 9:00–9:05 a.m. — Welcome and Introduction of Keynote Speaker
- 9:05–9:45 a.m. — Keynote Speaker and Q&A
- 9:45–10:00 a.m. — Break
- 10:00–10:50 a.m. — Panel Discussion 1
- 10:50–11:05 a.m. — Break
- 11:05–11:55 a.m.— Panel Discussion 2
- 11:55 a.m.–12 noon — Close and Networking
Keynote Speaker
- Caitlin Frazer (Col ’09, Batten ’10) — Executive Director, National Security Commission on Emerging Biotechnology
Panel 1 — Capitalizing on Capital: Startups and the Fuel of Funding
Moderator
- Nikki Hastings, PhD (Engr ’08) — Executive Director, CvilleBioHub
Panelists
- Jim Cheng (Darden ’87) — Founder & Co-Chair, CAV Angels
- Payam Pourtaheri (Engr ’16) — Founder & CEO, AgroSpheres
- Ben Schrag, PhD — SBIR/STTR Program Director & Policy Liaison, National Science Foundation
Panel 2 — Navigating the Tape: Policy and Regulation in Ever-Changing Innovation
Moderator
- Daniel Kracov (Law ’88) — Partner, Arnold & Porter
Panelists
- Kristen Riemenschneider (Engr ’01, Law ’06) — Partner, Freshfields Bruckhaus Deringer
- Chringma Sherpa, PhD (Grad ’14) — CMC Reviewer, Office for Biotechnology Products at FDA
Brought to you in partnership with CvilleBioHub, DC Hoos, Deloitte and UVA Licensing & Venture Group
For more information, please contact Alumni Career Services at apn@virginia.edu